Manganese-deposited iron oxide promotes tumor-responsive ferroptosis that synergizes the apoptosis of cisplatin

Junjie Cheng,Yang Zhu,Xin Xing,Jianmin Xiao,Hui Chen,Hongwei Zhang,Dan Wang,Yuanyuan Zhang,Guilong Zhang,Zhengyan Wu,Yangzhong Liu
DOI: https://doi.org/10.7150/thno.53346
IF: 11.6
2021-01-01
Theranostics
Abstract:<p><b>Background:</b> Ferroptosis is a form of iron-dependent programmed cell death that differs from apoptosis with regards to both mechanism and cell morphology. Therefore, ferroptotic-based cancer therapy has shown significant potential to overcome the weaknesses of conventional therapeutics mediated by apoptosis pathways. Effective ferroptosis can be induced by the intracellular Fenton reaction that is dependent on the adequate supply of iron ions and H<sub>2</sub>O<sub>2</sub> in cells. However, these are often insufficient due to intrinsic cellular regulation.</p><p><b>Methods:</b> In this study, we designed a cisplatin prodrug-loaded manganese-deposited iron oxide nanoplatform (Pt-FMO) to trigger intracellular cascade reactions that lead to generation of reactive oxygen species (ROS) to enhance ferroptotic effect. The Pt-FMO causes the tumor microenvironment responsive to release manganese, iron ions and Pt-drugs. As manganese is an element that is able to catalyze the Fenton reaction more effectively than iron, coupled with the Pt-drugs that can promote generation of H<sub>2</sub>O<sub>2</sub> in cells, the Pt-FMO is expected to significantly strengthen catalysis of the Fenton reaction, which favors the ferroptotic effect. Moreover, the Pt-drugs will eventually function as cisplatin. Thus, Pt-FMO is an ideal candidate for tumor ferroptotic combined with apoptotic treatment.</p><p><b>Results:</b> <i>In vivo</i> results demonstrated that, at a dosage of only 8.89% Pt content, Pt-FMO is able to achieve a similar treatment effect as cisplatin. Hence, Pt-FMO exhibited significantly lower systemic toxicity compared to cisplatin. Additionally, Pt-FMO exhibits effective <i>T<sub>2</sub></i>-weighted MRI enhancement for tumor imaging.</p><p><b>Conclusion:</b> The Pt-FMO nanoplatform is designed to introduce mutual beneficial cascade reactions for promoting ferroptosis and apoptosis in combination with tumor MRI. The Pt-FMO system, which causes ferroptosis combined with apoptosis, can efficiently induce tumor cell death.</p>
medicine, research & experimental
What problem does this paper attempt to address?